Evaluation of Marginal Bone Loss (MBL) 12 Months Post-loading of Implants Supporting Individual Crowns, Based on the Height of the Intermediate Abutment and Its Placement Time. Immediate Abutments of 2 or 3 Mm Show the Lowest MBL, Whereas 1.5 Mm or Delayed Abutments Are Associated with Higher MBL.

NCT ID: NCT06667531

Last Updated: 2024-10-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

54 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-15

Study Completion Date

2024-06-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objectives:To determine which combination of abutment height and timing of placement is most effective in reducing marginal bone loss (MBL).

Materials and Methods: 54 patients received at least one single screw-retained crown on an implant replacing a posterior tooth (60 implants). The implants were divided into six treatment groups based on the height (1.5 mm; 2 mm; 3 mm) and timing of placement (immediate: surgery 1; delayed: surgery 2) of the intermediate abutment: group 1 (height 3; surgery1), group 2 (height 2; surgery1), group 3 (height 1.5; surgery1), group 4 (height 3; surgery2), group 5 (height 2; surgery2), group 6 (height 1.5; surgery2). Mesial and distal linear radiographic measurements (from the implant shoulder to the bone crest) were performed at five follow-up times: implant surgery, crown placement (T1), and at 3 (T2), 6 (T3), and 12 months after loading (T4). Partial and total MBL were compared among the treatment groups.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All installed implants were BTI UnicCa® implants with a flat tetragonal internal connection (BTI Implant System, Vitoria, Spain) of universal (4.1 mm) or wide (5.5 mm) diameter. On all implants, anti-rotational intermediate abutments Ti Golden® UNIT (BTI Implant System, Vitoria, Spain) of universal (4.1 mm) or wide (5.5 mm) width and 1.5 mm, 2.0 mm, or 3.0 mm height were connected, either immediately during the installation surgery (protocol in one phase: one abutment - one time) or delayed during the second surgery procedure 8 weeks after installation (protocol in two phases: submerged implant). (Figure 1). For all patients, standardized digital intraoral radiographs with a silicone key and Rhin ring positioner were recorded during the surgical installation of the implant (baseline), during the placement of the prosthetic crown (8 weeks after surgery), and at 3, 6, and 12 months after prosthetic loading.

* Surgical Procedures. Patients received a complete clinical (periodontal chart) and radiographic (intraoral radiographs, orthopantomography, and CBCT) examination. All surgical procedures were performed by the same surgeon (JQH) under local anesthesia (Artinibsa®; Inibsa Dental SLU, Barcelona, Spain). The implant size was selected based on digital planning with CBCT (Planmeca Romexis Software) according to the quantity and quality of bone. Prior to surgery, the thickness of the soft tissue (from the mucosal surface to the crestal bone) at the implant placement site was measured with a periodontal probe (15 mm, PCP UNC 15; HuFriedy). A conventional placement protocol was followed, with delayed installation of the implant in a fully healed socket (minimum 16 weeks of healing after tooth extraction). Osteotomy was performed without irrigation at low revolutions (100 rpm) following the defined protocol according to implant size and bone density. All implants were placed 1.5 mm subcrestally. All patients received pharmacological prescription with antibiotics (Amoxicillin 1 g every 12 hours for 7 days) or clindamycin in case of allergy, anti-inflammatory medication (Dexketoprofen 25 mg every 8 hours for 3 days), and probiotics (1 sachet per day for 1 week), in addition to postoperative care instructions: pressure with gauze for 5 minutes, application of ice for 10 minutes, soft and cold diet for the first 24 hours, and rinses with 0.12% chlorhexidine (Perioaid; Dentaid SL; Cerdanyola, Spain) twice a day for 7 days. Sutures were removed after 7 days.
* Restorative Procedures. Eight weeks after the implant installation surgery, the platforms of the submerged implants were exposed and the intermediate abutment was connected with a torque of 35 Ncm. Ten weeks after surgery and after increasing the intermediate abutment torque to 35 Ncm on the non-submerged implants, the prosthetic phase began for all cases. All definitive implant-supported prostheses were unitary screw-retained metal-ceramic crowns. Records for the laboratory were obtained in all cases through digital intraoral scanning (iTero®; Align Technology Inc; San José; California, USA). The CAD design of the restorations was done using Exocad Software. The CAM fabrication of the restorations involved milling the metal framework and layering the ceramic covering on a printed model. The unitary crowns were screwed in 2 weeks after the scanning phase with a prosthetic screw torque of 20 Ncm (conventional loading for all cases: 12 weeks after implant placement surgery). The screw channels were sealed with Teflon and compact composite (GrandioSo; Voco GmbH; Cuxhaven, Germany). Occlusion was adjusted, and the adequacy of contact points and gingival sealing was checked.
* Radiographic Evaluation. Standardized digital intraoral radiographs with a silicone key and Rhin ring positioner (Planmeca Prox + Planmeca Prosensor HD; Planmeca Oy; Helsinki, Finland) were obtained at implant placement (baseline), at definitive crown placement (T1), and at 3 months (T2), 6 months (T3), and 12 months (T4) after functional loading. For MBL measurement, the Planmeca Romexis dental imaging software platform was used. Linear measurements were taken in each intraoral radiograph from the most mesial and distal point of the implant shoulder to the crestal bone. The magnification of the radiographs was corrected based on the radiographic measurement of the height and width of each implant, from which each linear MBL measurement was calibrated and recalculated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Marginal Bone Loss

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

marginal bone loss abutment height abutment placement timing

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This controlled clinical trial aims to evaluate changes in peri-implant marginal bone levels during the first year of function around platform-switched implants placed 1.5 mm subcrestally and connected to intermediate abutments of heights 1.5, 2, and 3 mm, placed immediately at the time of the first surgery or delayed at the time of the second surgery.

54 patients received at least one single screw-retained crown on an implant replacing a posterior tooth (60 implants). The implants were divided into six treatment groups based on the height (1.5 mm; 2 mm; 3 mm) and timing of placement (immediate: surgery 1; delayed: surgery 2) of the intermediate abutment: group 1 (height 3; surgery 1), group 2 (height 2; surgery 1), group 3 (height 1.5; surgery 1), group 4 (height 3; surgery 2), group 5 (height 2; surgery 2), group 6 (height 1.5; surgery 2). Mesial and distal linear radiographic measurements (from the implant shoulder to the bone crest) were performed at five follow-up times: implant
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators
Immediately after the placement of the implant, the subject was randomly assigned to one of the six treatment groups by opening a numbered sealed envelope from a computer-generated randomization list. Consequently, the surgeon was unaware of each subject's group assignment until the implant was installed. From that point onward, based on the random assignment, the intermediate abutments of the three heights were screwed with a torque lower than the implant insertion torque to the internal connection either immediately during the same installation procedure (one-abutment-one-time protocol) or delayed during the second surgery procedure at 8 weeks after the installation (two-stage protocol: submerged implant).

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1 (height 3; surgery 1)

Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 3 mm.

Group Type ACTIVE_COMPARATOR

Implant

Intervention Type PROCEDURE

Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 3 mm.

Group 2 (height 2; surgery 1)

Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 2 mm.

Group Type ACTIVE_COMPARATOR

Implant

Intervention Type PROCEDURE

Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 2 mm.

Group 3 (height 1.5; surgery 1)

Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 1.5 mm.

Group Type ACTIVE_COMPARATOR

Implant

Intervention Type PROCEDURE

Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 1.5 mm.

Group 4 (height 3; surgery 2)

Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 3 mm.

Group Type ACTIVE_COMPARATOR

Implant

Intervention Type PROCEDURE

Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 3 mm.

Group 5 (height 2; surgery 2)

Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 2 mm.

Group Type ACTIVE_COMPARATOR

Implant

Intervention Type PROCEDURE

Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 2 mm.

Group 6 (height 1.5; surgery 2)

Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 1.5 mm.

Group Type ACTIVE_COMPARATOR

Implant

Intervention Type PROCEDURE

Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 1.5 mm.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Implant

Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 3 mm.

Intervention Type PROCEDURE

Implant

Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 2 mm.

Intervention Type PROCEDURE

Implant

Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 1.5 mm.

Intervention Type PROCEDURE

Implant

Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 3 mm.

Intervention Type PROCEDURE

Implant

Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 2 mm.

Intervention Type PROCEDURE

Implant

Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 1.5 mm.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Oral Surgery Oral Surgery Oral Surgery

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy adults.
* Plaque and bleeding indices below 10%.
* Absence of chronic periodontal diseases (periodontitis) or acute periodontal diseases (periodontal abscess).
* Presence of intact alveolar walls.
* Sufficient bone height and width.
* Need for restoration of a tooth in the posterior maxillary or mandibular region (premolars and molars).
* Incorporation into a periodontal maintenance program.

Exclusion Criteria

* History of systemic disease or radiotherapy contraindicating bone surgery.
* Pregnant or breastfeeding women.
* Smokers of more than 10 cigarettes per day.
* Parafunctional habits.
* Alcohol or drug abuse.
* Narrow interproximal spaces (less than 9 mm).
* Placement of implants flapless or post-extraction.
* Insertion torque during implant placement below 35 Ncm.
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Salamanca

OTHER

Sponsor Role collaborator

Quintas Hijós Clínica Dental

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jacobo Quintas Hijós

Medical Director

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Esteban Pérez Pevida, Dentistry

Role: STUDY_DIRECTOR

University of Salamanca

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Salamanca

Salamanca, Salamanca, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

References

Explore related publications, articles, or registry entries linked to this study.

Quintas-Hijos J, Perez-Pevida E. Influence of intermediate abutment height and timing of placement on marginal bone loss in single implant-supported crowns: a 12-month follow-up randomized clinical trial. Clin Oral Investig. 2025 May 8;29(6):291. doi: 10.1007/s00784-025-06364-8.

Reference Type DERIVED
PMID: 40335732 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

C.I. PI22/324

Identifier Type: -

Identifier Source: org_study_id